1. Segra Biogenesis Corporation
Science-Integrity-Quality
December 2015

2. Medical Marijuana
Medical Marijuana is legal nationally in
Canada
Canada just elected a majority Liberal
government that’s legalizing cannabis
23 U.S States currently allow medical
marijuana
Recreational use expected to be legalized in
growing number of states in 2016
Worldwide interest in cannabis as medicine
2
State of the Nation 2015 -2016

3. What's Next?
Cultivation of cannabis in Canada is regulated like
a pharmaceutical/prescription drug
Liberalized does not mean less regulatory control
Enforcement is becoming more stringent
It’s estimated that up to 35% of crops that are
produced by Licensed Producers are destroyed for
failing to meet QA standards
Licensed Producers don’t know exactly what
genetics they are selling and have adopted street
names for strains
3

4. Why Segra?
Why?
Quality science is the foundation of the Segra team
The Segra scientific team, headed up by Dr. Brunstein, an expert in quality
systems, strategically built the living 1,200 page Quality System for
managing each and every process in the facility to regulatory standards
The Company then submitted a highly detailed MMPR application based on the
Quality System, setting a new gold standard
Dr. She, Quality Assurance Manager/Senior Scientist authored the Quality Pre-
Licensing Report that details how we meet MMPR regulations
Team Expertise:
Botanical Sciences, Genetics, Microbiology Analytical Chemistry with
specialties in: Biochemistry, Clinical Diagnostics, Neuroscience, Immunology,
and Organic chemistry
4
Segra is uniquely positioned to be the industry standard

5. Science Management
Dr. John Brunstein, BSc, PhD – Chief Scientific Officer
Ph.D.: Molecular biology of viruses
Three-year fellowship at the University of Helsinki,
clinical molecular virology
University of British Columbia
Clinical Assistant Professor in Department of
Pathology and Laboratory Medicine
Children’s and Women’s Health Center of BC
Oversaw molecular microbiology for 7 years
Chief Scientific Officer at the Centre for Translational
and Applied Genomics
Dr. Kevin She, BA, MSc, PhD – QA Manager/Senior Scientist
Extensive experience in writing programs,
procedures, and quality assurance protocols
Industrial microbiology
Discovery of novel antibiotics
5

6. Management
Todd McMurray - President, Director, Founder
Mr. McMurray is a business and corporate development professional with
over 26 years of experience in:
planning, financing, and promoting the strategic initiatives of public
and private companies
This experience includes over 20 years as a director and or senior
officer of Canadian listed companies
Manjit Sidhu, C.A. - Chief Financial Officer
Chartered accountant who is currently the Assistant Deputy Minister at
the BC Ministry of Health
Kevin Mehr, B.Sc., Director
An expert in the fields of microbiology and Genomics
Manjit Claire, CCIM, Director
Real estate specialist with over 22 years experience
Christine Thomson – Corporate Secretary
Over 20 years pubco experience including listing companies on NYSE,
TSX, TSX.V and AIM
6

7. Digital Branding - Branding, Sales, Marketing
Digital Marketing
Use of programmatic advertising, data science,
algorithms, machine learning and predicative
behavioral science will deliver calculable results
and optimum ROI
Social Media
Fully leveraged, fully networked
Natural Health Products (NHP)
Developed first product, Blissful Sleep, now
Health Canada approved
Natural product development system/pipeline
Higher than required standards
NHP’s allow distribution of Segra brand without
the regulatory limitations of the cannabis part of
the business
7
Press Release

8. The Science of Production
End to end industry leading Quality Systems for
managing both medical cannabis and natural health
products
A core aspect of the Quality Assurance protocol (QA)
is the capacity for genetic strain identification or
genotyping (fingerprinting) of plants
The resulting genomic fingerprint library (IP) will be a
substantial asset to the company as well as a revenue
generating service
8

9. Major Project Milestones
Completed 1st round of funding
Created extensive market research database
Recruited top scientific team and Advisory Board
Secured property for the Marijuana for Medical
Purposes Regulations (MMPR) facility within the
Agricultural Land Reserve at a substantial discount
to the market
Built fully functioning Quality System for the
complete management of an MMPR Facility
9

10. Major Project Milestones- Continued
Submitted highly comprehensive 1,200 page
MMPR application to Health Canada to become a
Licensed Producer
Built fully functioning natural product Quality
System for the distribution of NHP’s exceeding
Health Canada standards
Filed natural product number application with
Health Canada for Blissful Sleep
Blissful Sleep granted natural product number by
Health Canada - #80065538
10

11. Cannabis and NHP Research
Laboratory science will reveal and develop novel
strains with unique and specific health applications
Segra will be able to conduct and support clinical
trials with current proven team members
Scaling our science to continually drive down costs
Segra will ensure that patients as well as
institutions get the same product quality and
efficacy every time
Segra will mitigate risks such as pesticides,
contamination with unknown adulterants, bacterial,
fungal, and arthropod contamination
11

12. Natural Health Product
Division
Segra’s natural health products quality assurance
system fully implements protocols for the Canada
Vigilance Program (CVP)
Management Structure and Job Descriptions
Business Plan clearly defines responsibilities and accountabilities
to support:
Operations
Efficiency
Continual improvement
Regulatory compliance
12

13. Use of Proceeds
Genotyping equipment, location
improvements, and lease
Architectural drawings
Salaries
NHP Manufacturing
Marketing/Branding
Working Capital
Contingency
13

14. THANKS FOR YOUR TIME
604.377.1218
todd@segrabiogen.com
www.segrabiogen.com
14